The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib trial of neoadjuvant/adjuvant durvalumab +/- tremelimumab in locally advanced renal cell carcinoma (RCC).
 
Moshe Chaim Ornstein
Consulting or Advisory Role - Eisai; Exelixis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis
 
Joseph Zabell
No Relationships to Disclose
 
Laura S. Wood
Consulting or Advisory Role - Eisai; EMD Serono; Merck
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; EMD Serono; Genentech/Roche; Merck; Pfizer
 
Brian Hobbs
Stock and Other Ownership Interests - Presagia
Consulting or Advisory Role - Simulstat
Research Funding - Amgen
(OPTIONAL) Uncompensated Relationships - Presagia
 
Sarah Devonshire
No Relationships to Disclose
 
Allison Martin
No Relationships to Disclose
 
Kimberly D. Allman
Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis
Speakers' Bureau - Amgen; Exelixis
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Exelixis
 
Arpit Rao
Consulting or Advisory Role - Lilly (Inst)
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - Dendreon
 
Steven Campbell
No Relationships to Disclose
 
Venkatesh Krishnamurthi
No Relationships to Disclose
 
Brian I. Rini
Leadership - MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Merck; Peloton Therapeutics; Pfizer; Roche/Genentech; Surface Oncology; synthorx
Research Funding - AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer